Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX)

CUSIP: 87164F105

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 7 signals
Share change
+9,231,771
Put/Call ratio
38%
SEC-reported price per share
$13.22
Number of holders
214
Value change
+$87,204,107
Number of buys
113
Open additional details 1 more signal available
Number of sells
89
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
86,328,130

Security key

87164F105

Report period

Q4 2024

Institutions

214

Top holders

10

Ownership snapshot

Top reported holders of SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Kynam Capital Management, LP
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2024
13D/G 13F Lead comparable stake: 10% 13D/G row: Kynam Capital Management, LP Showing 1-6 of 15 holder rows.

Quick read

Kynam Capital Management, LP leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Kynam Capital Management, LP's linked filing trail.
Comparable ownership Top 5
Kynam Capital Management, LP 10%
BlackRock, Inc. 9.5%
WELLINGTON MANAGEMENT GROUP LLP 5.8%
VANGUARD GROUP INC 5.7%
Eversept Partners, LP 4.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Kynam Capital Management, LP
13D/G 13F
Company
10%
$113,571,600
8,520,000 shares
$0 31 Dec 2024
BlackRock, Inc.
13F
Company
13F
9.5%
$158,601,714
8,239,050 shares
30 Sep 2024
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
5.8%
$95,980,040
4,985,976 shares
30 Sep 2024
VANGUARD GROUP INC
13F
Company
13F
5.7%
$94,074,250
4,886,974 shares
30 Sep 2024
Eversept Partners, LP
13F
Company
13F
4.8%
$79,027,275
4,105,313 shares
30 Sep 2024
Avoro Capital Advisors LLC
13F
Company
13F
4.5%
$74,852,412
3,888,437 shares
30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
214
Shares
98,036,463
Rows available
214
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
208
Q4 2024 holders
214
Holder diff
6
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .